The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases
- PMID: 27725792
- PMCID: PMC5048023
- DOI: 10.1155/2016/1014248
The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases
Abstract
Background. The Musculoskeletal Tumor Society (MSTS) scoring system measures function and is commonly used but criticized because it was developed to be completed by the clinician and not by the patient. We therefore evaluated if there is a difference between patient and clinician reported function using the MSTS score. Methods. 128 patients with bone metastasis of the lower (n = 100) and upper (n = 28) extremity completed the MSTS score. The MSTS score consists of six domains, scored on a 0 to 5 scale and transformed into an overall score ranging from 0 to 100% with a higher score indicating better function. The MSTS score was also derived from clinicians' reports in the medical record. Results. The median age was 63 years (interquartile range [IQR]: 55-71) and the study included 74 (58%) women. We found that the clinicians' MSTS score (median: 65, IQR: 49-83) overestimated the function as compared to the patient perceived score (median: 57, IQR: 40-70) by 8 points (p < 0.001). Conclusion. Clinician reports overestimate function as compared to the patient perceived score. This is important for acknowledging when informing patients about the expected outcome of treatment and for understanding patients' perceptions.
Conflict of interest statement
One author (Stein J. Janssen) certifies that he has received an amount less than USD 10,000 from the Anna Foundation (Oegstgeest, Netherlands), an amount less than USD 10,000 from the De Drie Lichten Foundation (Hilversum, Netherlands), an amount less than USD 10,000 from the KWF Kankerbestrijding (Amsterdam, Netherlands), and an amount less than USD 10,000 from the Michael van Vloten Foundation (Rotterdam, Netherlands).
References
-
- Cheng E. Y. Prospective quality of life research in bony metastatic disease. Clinical Orthopaedics and Related Research. 2003;(415, supplement):S289–S297. - PubMed
-
- Quinn R. H., Randall R. L., Benevenia J., Berven S. H., Raskin K. A. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. The Journal of Bone & Joint Surgery—American Volume. 2013;95(20):1887–1895. - PubMed
-
- Enneking W. F., Dunham W., Gebhardt M. C., Malawar M., Pritchard D. J. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clinical Orthopaedics and Related Research. 1993;(286):241–246. - PubMed
-
- Clohisy D. R., Le C. T., Cheng E. Y., Dykes D. C., Thompson R. C., Jr. Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastases. Journal of Orthopaedic Research. 2000;18(1):1–9. doi: 10.1002/jor.1100180102. - DOI - PubMed